Combination therapy with serotonin reuptake inhibitors and interferon β-1a (Avonex) in the treatment of multiple sclerosis:: a pilot study

被引：0
|
作者：
Potter, DL
Hart, DE
机构：
来源：
ANNALS OF NEUROLOGY | 1999年 / 46卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：495 / 495
页数：1
相关论文
共 50 条
  • [1] Quality of life in multiple sclerosis:: influence of interferon-β1a (Avonex®) treatment
    Vermersch, P
    de Seze, J
    Delisse, B
    Lamaire, S
    Stojkovic, T
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2002, 8 (05) : 377 - 381
  • [2] The neurodegenerative process in multiple sclerosis and the possible neuroprotective effect of treatment with β-interferon 1a (Avonex)
    Davydovskaya M.V.
    Boiko A.N.
    Podoprigora A.E.
    Pronin I.N.
    Kornienko V.N.
    Gusev E.I.
    [J]. Neuroscience and Behavioral Physiology, 2013, 43 (8) : 907 - 912
  • [3] The neurodegenerative process in multiple sclerosis and the possible neuroprotective effect of treatment with β-interferon 1a (avonex)
    Davydovskaya, M. V.
    Boiko, A. N.
    Podoprigora, A. E.
    Pronin, I. N.
    Kornienko, V. N.
    Gusev, E. I.
    [J]. ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2012, 112 (07) : 36 - 41
  • [4] A pilot safety and tolerability study of interferon beta 1a in combination with azathioprine in multiple sclerosis
    Moreau, T
    Blanc, S
    Riche, G
    Nony, P
    Confavreux, C
    [J]. NEUROLOGY, 2001, 56 (08) : A353 - A353
  • [5] Treatment of disease progression in relapsing multiple sclerosis with combination therapy of interferon-β-1a (Avonex®) plus pulse steroids, cyclophosphamide, and/or mycophenolate mofetil
    Stuart, WH
    Court, D
    English, J
    [J]. MULTIPLE SCLEROSIS, 2004, 10 (7032): : S265 - S265
  • [6] Combination of IFNβ-1a (Avonex®) and mycophenolate mofetil (Cellcept®) in multiple sclerosis
    Vermersch, P.
    Waucquier, N.
    Michelin, E.
    Bourteel, H.
    Stojkovic, T.
    Ferriby, D.
    de Seze, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (01) : 85 - 89
  • [7] Neuropsychological effects of Avonex® (interferon-β-1a) in relapsing multiple sclerosis (MS)
    Fischer, JS
    Priore, R
    Jacobs, L
    Cookfair, D
    Rudick, R
    Herndon, R
    Richert, J
    Salazar, A
    Goodkin, D
    Granger, C
    Simon, J
    Grafman, J
    Lezak, M
    O'Reilly, K
    Schacter, M
    Shucard, D
    Davidson, A
    Wende, K
    [J]. NEUROLOGY, 1998, 50 (04) : A32 - A33
  • [8] Neurodegenerative process in multiple sclerosis and a possible neuroprotective effect of β-interferon 1a (avonex)
    Davydovskaya, M. V.
    Boiko, A. N.
    Podoprigora, A. E.
    Pronin, I. N.
    Kornienko, V. N.
    Gusev, E. I.
    [J]. ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2012, 112 (09) : 129 - 135
  • [9] Pilot trial of interferon β-1a (AVONEX®) in JRA.
    Sundel, RP
    Wallace, CA
    Zurakowski, D
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S272 - S272
  • [10] The treatment of MS-related cognitive impairment:: Final pilot study results on combination modafinil (Provigil®) and interferon β-1a (Avonex®)
    Wilken, JA
    Wallin, MT
    Sullivan, CL
    Chapman, J
    Kane, RL
    Rossman, H
    Lawson, S
    Simsarian, J
    Saunders, C
    Shin, R
    Mikszewski, J
    Kerr, D
    Quig, ME
    [J]. NEUROLOGY, 2006, 66 (05) : A32 - A32
12345